Fundraising Fox
Alterome Therapeutics, Inc.
San Diego, US · Founded 2021 · Delaware corporation · 42 employees on LinkedIn · 6 known investors
Find your way into Alterome Therapeutics, Inc.
Sign up to see every warm intro you have to Alterome Therapeutics, Inc.
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Alterome Therapeutics, Inc. team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Alterome is a clinical-stage precision oncology company developing small-molecule, alteration-specific cancer therapies, with two internally discovered drug candidates in the clinic. It focuses on hard-to-drug cancer targets such as mutant KRAS and mutant AKT E17K across malignancies including non-small cell lung, pancreatic, colorectal, endometrial, and breast cancers.
Founders & leadership
Alterome Therapeutics, Inc. was founded in 2021 by Eric A. Murphy.
Board
Investors · 6
How we know: Canaan Partners's portfolio page · Not right? Tell us
How we know: Nextech Invest's portfolio page · a partner's Signal profile · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: OrbiMed's portfolio page · a partner's Signal profile · the VCSheet dataset · Not right? Tell us
How we know: Vida Ventures's portfolio page · a partner's Signal profile · the VCSheet dataset · Not right? Tell us
How we know: the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$63.8M disclosed across 1 round · 2021
▶$63.8MraisedJan 2022 · 9 investors · BiotechnologyRule 506(b)
- Eric A. MurphyExecutive Officer, Director, Promoter
- Thilo SchroederDirector
- Ryan B. CorcoranDirector, Promoter
- Carl GordonDirector
- Arjun GoyalDirector
- Offering amount
- $63.8M
- Amount sold
- $63.8M
- First sale
- Dec 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Alterome Therapeutics, Inc. went on to found or lead other companies.
Related companies · 8
Companies working in the same space as Alterome Therapeutics, Inc..
Frequently asked questions
- What does Alterome Therapeutics, Inc. do?
- Alterome is a clinical-stage precision oncology company developing small-molecule, alteration-specific cancer therapies, with two internally discovered drug candidates in the clinic. It focuses on hard-to-drug cancer targets such as mutant KRAS and mutant AKT E17K across malignancies including non-small cell lung, pancreatic, colorectal, endometrial, and breast cancers.
- Who founded Alterome Therapeutics, Inc.?
- Alterome Therapeutics, Inc. was founded by Eric A. Murphy in 2021.
- Who are Alterome Therapeutics, Inc.'s investors?
- Alterome Therapeutics, Inc.'s investors include Canaan Partners, Nextech Invest, OrbiMed, Vida Ventures, Digitalis Ventures, NVIDIA.
- How much funding has Alterome Therapeutics, Inc. raised?
- Alterome Therapeutics, Inc. has disclosed $63.8M raised across 1 round.
- Where is Alterome Therapeutics, Inc. headquartered?
- Alterome Therapeutics, Inc. is headquartered in San Diego, US.